Champions Oncology Inc (CSBR)
4.52
-0.11
(-2.38%)
USD |
NASDAQ |
May 24, 16:00
4.61
+0.09
(+1.99%)
Pre-Market: 20:00
Champions Oncology Total Assets (Quarterly): 26.79M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 26.79M |
October 31, 2023 | 28.29M |
July 31, 2023 | 29.91M |
April 30, 2023 | 34.31M |
January 31, 2023 | 36.15M |
October 31, 2022 | 36.36M |
July 31, 2022 | 34.39M |
April 30, 2022 | 35.38M |
January 31, 2022 | 33.58M |
October 31, 2021 | 29.30M |
July 31, 2021 | 28.11M |
April 30, 2021 | 27.59M |
January 31, 2021 | 25.26M |
October 31, 2020 | 25.76M |
July 31, 2020 | 22.82M |
April 30, 2020 | 20.75M |
January 31, 2020 | 15.08M |
October 31, 2019 | 13.95M |
July 31, 2019 | 13.36M |
April 30, 2019 | 11.26M |
January 31, 2019 | 10.91M |
October 31, 2018 | 10.24M |
July 31, 2018 | 8.391M |
April 30, 2018 | 8.078M |
January 31, 2018 | 7.095M |
Date | Value |
---|---|
October 31, 2017 | 6.493M |
July 31, 2017 | 6.467M |
April 30, 2017 | 8.011M |
January 31, 2017 | 7.546M |
October 31, 2016 | 8.044M |
July 31, 2016 | 7.849M |
April 30, 2016 | 5.777M |
January 31, 2016 | 7.145M |
October 31, 2015 | 7.582M |
July 31, 2015 | 9.848M |
April 30, 2015 | 12.05M |
January 31, 2015 | 2.833M |
October 31, 2014 | 3.311M |
July 31, 2014 | 5.678M |
April 30, 2014 | 8.867M |
January 31, 2014 | 10.47M |
October 31, 2013 | 10.50M |
July 31, 2013 | 10.67M |
April 30, 2013 | 11.65M |
January 31, 2013 | 13.01M |
October 31, 2012 | 4.225M |
July 31, 2012 | 5.145M |
April 30, 2012 | 6.922M |
January 31, 2012 | 8.865M |
October 31, 2011 | 9.872M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.36M
Minimum
Jul 2019
36.36M
Maximum
Oct 2022
27.22M
Average
28.11M
Median
Jul 2021
Total Assets (Quarterly) Benchmarks
AIM ImmunoTech Inc | 16.19M |
Perspective Therapeutics Inc | 278.29M |
Protalix BioTherapeutics Inc | 89.82M |
Electromed Inc | 48.90M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 28.84M |
Shareholders Equity (Quarterly) | -2.058M |
Current Ratio | 0.6008 |